vimarsana.com

Page 22 - சீட்டில் புற்றுநோய் பராமரிப்பு கூட்டணி News Today : Breaking News, Live Updates & Top Stories | Vimarsana

2nd COVID-19 vaccine set for OK in U S with panel endorsement

2nd COVID-19 vaccine set for OK in U.S. with panel endorsement Updated Dec 17, 2020; Posted Dec 17, 2020 A nurse prepares a shot as a study of a possible COVID-19 vaccine, developed by the National Institutes of Health and Moderna Inc., gets underway in Binghamton, N.Y. On Thursday, Dec. 17, 2020, a panel of independent experts is meeting to discuss a vaccine made by Moderna. The panel s review for the Food and Drug Administration is the next-to-last step before the agency decides whether the shots can be used on an emergency basis. (AP Photo/Hans Pennink)AP Facebook Share WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign.

2nd COVID-19 vaccine set for OK in US with panel endors

WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign. The Food and Drug Administration is expected to follow the recommendation and quickly OK the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up. Once emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.

FDA panel recommends 2nd COVID-19 vaccine made by Moderna

FDA panel recommends 2nd COVID-19 vaccine made by Moderna Matthew Perrone, and Lauran Neergaard, Associated Press Share This WASHINGTON (AP) A government advisory panel endorsed a second COVID-19 vaccine Thursday, paving the way for the shot to be added to the U.S. vaccination campaign. The Food and Drug Administration is expected to follow the recommendation and quickly OK the vaccine from Moderna and the National Institutes of Health. The FDA advisers, in a 20-0 vote, agreed the benefits of the vaccine outweighed the risks for those 18 years old and up. Once emergency use authorization is granted, Moderna will begin shipping millions of doses, earmarked for health workers and nursing home residents, to boost the largest vaccination effort in U.S. history.

Washington Mesothelioma Victims Center Urges a Former Shipyard Worker with Mesothelioma in Washington State to Call Attorney Erik Karst of Karst von Oiste To Discuss Compensation-It Might Exceed $1,000,000

Washington Mesothelioma Victims Center Urges a Former Shipyard Worker with Mesothelioma in Washington State to Call Attorney Erik Karst of Karst von Oiste To Discuss Compensation-It Might Exceed $1,000,000
einnews.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from einnews.com Daily Mail and Mail on Sunday newspapers.

© 2025 Vimarsana

vimarsana © 2020. All Rights Reserved.